Cargando…
Molecular profiling identifies prognostic markers of stage IA lung adenocarcinoma
We previously showed that different pathologic subtypes were associated with different prognostic values in patients with stage IA lung adenocarcinoma (AC). We hypothesize that differential gene expression profiles of different subtypes may be valuable factors for prognosis in stage IA lung adenocar...
Autores principales: | Zhang, Jie, Shao, Jinchen, Zhu, Lei, Zhao, Ruiying, Xing, Jie, Wang, Jun, Guo, Xiaohui, Tu, Shichun, Han, Baohui, Yu, Keke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650383/ https://www.ncbi.nlm.nih.gov/pubmed/29088828 http://dx.doi.org/10.18632/oncotarget.20420 |
Ejemplares similares
-
Pathologic subtype-defined prognosis is dependent on both tumor stage and status of oncogenic driver mutations in lung adenocarcinoma
por: Dong, Yu, et al.
Publicado: (2017) -
Histological evolution from primary lung adenocarcinoma harboring EGFR mutation to high‐grade neuroendocrine carcinoma
por: Zhao, Jikai, et al.
Publicado: (2017) -
Prognostic relevance of TTF-1 expression in stage I adenocarcinoma
por: Zhou, Chao, et al.
Publicado: (2017) -
Genomic profile and immune microenvironment in patients with relapsed stage IA lung adenocarcinoma
por: Yang, Lu, et al.
Publicado: (2020) -
Prognostic impact of noninvasive areas in resected pathological stage IA lung adenocarcinoma
por: Kinoshita, Fumihiko, et al.
Publicado: (2023)